CSF2RB (also known as cytokine receptor common subunit beta) is a common subunit to the following type I cytokine receptors:
References
- ^ a b c GRCh38: Ensembl release 89: ENSG00000100368 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000071714 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Woodcock JM, Zacharakis B, Plaetinck G, Bagley CJ, Qiyu S, Hercus TR, Tavernier J, Lopez AF (November 1994). "Three residues in the common beta chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF". The EMBO Journal. 13 (21): 5176–85. doi:10.1002/j.1460-2075.1994.tb06848.x. PMC 395466. PMID 7957082.
External links
|
---|
1–50 | |
---|
51–100 | |
---|
101–150 | |
---|
151–200 | |
---|
201–250 | |
---|
251–300 | |
---|
301–350 | |
---|
|
---|
Chemokine | |
---|
CSF | |
---|
Interferon | IFNAR (α/β, I) |
- Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
- Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
- Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
- Antibodies: Anifrolumab
- Faralimomab
- MEDI-545
- Rontalizumab
- Sifalimumab
- Decoy receptors: Bifarcept
|
---|
IFNGR (γ, II) |
- Antibodies: Emapalumab
- Fontolizumab
|
---|
IFNLR (λ, III) |
- See IL-28R (IFNLR) here instead.
|
---|
|
---|
Interleukin | |
---|
TGFβ | |
---|
TNF | |
---|
Others | JAK (inhibitors) | JAK1 |
- Abrocitinib
- Baricitinib
- Deuruxolitinib
- Filgotinib
- Momelotinib
- Oclacitinib
- Peficitinib
- Ruxolitinib
- Tofacitinib (tasocitinib)
- Upadacitinib
|
---|
JAK2 |
- Atiprimod
- AZD-1480
- Baricitinib
- CHZ868
- Cucurbitacin I (elatericin B, JSI-124)
- CYT387
- Deuruxolitinib
- Lestaurtinib
- NSC-7908
- NSC-33994
- Pacritinib
- Peficitinib
- Ruxolitinib
- SD-1008
- Tofacitinib (tasocitinib)
|
---|
JAK3 |
- Cercosporamide
- Decernotinib (VX-509)
- Peficitinib
- Ritlecitinib
- TCS-21311
- Tofacitinib (tasocitinib)
- WHI-P 154
- ZM-39923
- ZM-449829
|
---|
TYK2 | |
---|
|
---|
Others |
- Additional cytokine receptor modulators: Emfilermin
- Lestaurtinib
- Midostaurin
- Quizartinib
- Sorafenib
- Sunitinib
|
---|
|
---|
|
---|
IL-1 |
- Antagonists: AF-12198
- Anakinra
- IL-1RA
- Isunakinra
- Antibodies: Canakinumab
- Gevokizumab
- Lutikizumab
- Decoy receptors: Rilonacept (IL-1 Trap)
|
---|
IL-2 |
- Agonists: Adargileukin alfa
- Aldesleukin
- Celmoleukin
- Denileukin diftitox
- Interleukin 2
- Pegaldesleukin
- Teceleukin
- Tucotuzumab celmoleukin
- Antibodies: Basiliximab
- Daclizumab (dacliximab)
- Inolimomab
|
---|
IL-3 | |
---|
IL-4 |
- Antibodies: Dupilumab
- Pascolizumab
|
---|
IL-5 |
- Antibodies: Benralizumab
- Mepolizumab
- Reslizumab
- Antisense oligonucleotides: TPI ASM8
|
---|
IL-6 |
- Antibodies: ARGX-109
- Clazakizumab
- Elsilimomab
- mAb 1339
- Olokizumab
- Sarilumab
- Siltuximab
- Sirukumab
- Tocilizumab
- Levilimab
|
---|
IL-7 | |
---|
IL-8 |
- See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ) here instead.
|
---|
IL-9 | |
---|
IL-10 | |
---|
IL-11 | |
---|
IL-12 |
- Antibodies: Briakinumab
- Ustekinumab
|
---|
IL-13 |
- Antibodies: Anrukinzumab
- Lebrikizumab
- Tralokinumab
|
---|
IL-15 | |
---|
IL-17 |
- Antibodies: Brodalumab
- Ixekizumab
- Perakizumab
- Remtolumab
- Secukinumab
- Vunakizumab
|
---|
IL-18 | |
---|
IL-20 |
- Antibodies: Fletikumab (against IL-20)
|
---|
IL-21 |
- Antibodies: NNC0114-0005
- NNC0114-0006
|
---|
IL-22 |
- Antibodies: Fezakinumab (against IL-22)
|
---|
IL-23 |
- Agonists: Interleukin 23 (SGRF)
- Antibodies: Brazikumab
- Briakinumab
- Guselkumab
- Risankizumab
- Tildrakizumab
- Ustekinumab
|
---|
IL-27 | |
---|
IL-28 | |
---|
IL-31 | |
---|
IL1RL1 | |
---|
IL1RL2 | |
---|
Others | JAK | |
---|
Others |
- Unsorted: Efavaleukin alfa
- Efineptakin alfa
|
---|
|
---|